Vascular Alterations in the Choroid of Eyes Affected by Acute Macular Neuroretinopathy and Paracentral Acute Middle Maculopathy: Fresh Perspectives - Top-Institutions - MDSpire

Vascular Alterations in the Choroid of Eyes Affected by Acute Macular Neuroretinopathy and Paracentral Acute Middle Maculopathy: Fresh Perspectives

  • By

  • Nicola Valsecchi

  • Matteo Elifani

  • Chiara Veronese

  • Emilia Maggio

  • Antonio Moramarco

  • Mohammed Abdul Rasheed

  • Grazia Pertile

  • Kiran Kumar Vupparaboina

  • Jay Chhablani

  • Luigi Fontana

  • Maurizio Mete

  • February 11, 2026

  • 0 min

Share

Top Institutions in Ophthalmology

Brief introduction explaining scope and methodology.

  • #1

    Bascom Palmer Eye Institute
    Bascom Palmer Eye Institute

    Miami, FL

    Key Differentiators

    • Ophthalmology
    • Retina
    • Vascular Imaging

  • #2

    Massachusetts Eye and Ear Infirmary
    Massachusetts Eye and Ear Infirmary

    Boston, MA

    Key Differentiators

    • Ophthalmology
    • Retina
    • Neuro-ophthalmology

  • #3

    Johns Hopkins Wilmer Eye Institute
    Johns Hopkins Wilmer Eye Institute

    Baltimore, MD

    Key Differentiators

    • Ophthalmology
    • Retina
    • Imaging Research

  • #4

    University of California San Francisco (UCSF) Department of Ophthalmology
    University of California San Francisco (UCSF) Department of Ophthalmology

    San Francisco, CA

    Key Differentiators

    • Ophthalmology
    • Retina
    • Imaging

  • #5

    Moorfields Eye Hospital
    Moorfields Eye Hospital

    London, N/A

    Key Differentiators

    • Ophthalmology
    • Retina
    • Vascular Imaging

Original Source(s)

Vascular Alterations in the Choroid of Eyes Affected by Acute Macular Neuroretinopathy and Paracentral Acute Middle Maculopathy: Fresh Perspectives

  • by Nicola Valsecchi, Matteo Elifani, Chiara Veronese, Emilia Maggio, Antonio Moramarco, Mohammed Abdul Rasheed, Grazia Pertile, Kiran Kumar Vupparaboina, Jay Chhablani, Luigi Fontana, Maurizio Mete

  • February 11, 2026

Related Content

Atsena Reports LIGHTHOUSE data at ARVO

Atsena Therapeutics announced positive clinical data results from Part A of the LIGHTHOUSE study, a phase 1/2 clinical trial evaluating subretinal injection of ATSN-201 for the treatment of X-linked retinoschisis (XLRS). The data were presented at the 2025 Association for Research in Vision and Ophthalmology meeting in Salt Lake City, Utah.

  • May 1, 2025

  • 3 min
GLP-1 Eye Effects Raise Questions

Authors describe both potential retinal benefits and possible rare optic nerve risks, while emphasizing that long-term ocular safety data remain limited as use expands.

Centre for Sight launches "Eye Health MOT"

New service offers advanced diagnostics, early detection and reassurance

  • February 13, 2026

  • 2 min